Company: WHWK
Filing Date: 2025-01-31
Form Type: DEFM14A
Source: 0001193125-25-018470
Chunk: 122

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-31
Form: DEFM14A
Chunk 122
---
 outstanding voting power of the capital stock of Aadi or Aadi Sub after giving effect to the consummation of such transaction or series of related transactions. In particular, under and subject to the terms of the Divestiture Agreement, Aadi, Aadi Sub and their respective directors and executive officers, have agreed not to, and Aadi and Aadi Sub have agreed not to instruct, authorize or knowingly permit any of their respective employees, consultants or other representatives to, directly or indirectly:

| • |     | solicit, initiate, propose or knowingly induce the making, submission or announcement of, or knowingly encourage, 
 facilitate or assist any acquisition inquiry or acquisition proposal;                                             |

| • |     | furnish to any third person (other than Kaken or any of its affiliates) any                                                                                                                                                                                                                                                                                                                                          
 non-public information relating to Aadi or Aadi Sub or afford to any third person (other than Kaken or any of its affiliates) access to the business, properties, assets, books, records or other non-public information, or to any personnel, of Aadi or Aadi Sub, in any such case in connection with any actual or potential acquisition inquiry or acquisition proposal or with the intent to induce the making, 
 submission or announcement of, or to knowingly encourage, facilitate or assist, any acquisition inquiry or acquisition proposal;                                                                                                                                                                                                                                                                                     |

| • |     | participate or engage in discussions or negotiations with any third person (other than Kaken or any of its 
 affiliates) with respect to an acquisition inquiry or acquisition proposal;                                |

| • |     | authorize or commit to do any of the foregoing. |

Under and subject to the terms of the Divestiture Agreement, from the date of the Divestiture Agreement until Aadi receives the requisite stockholder approval, Aadi and Aadi Sub may, directly or indirectly through one or more of their representatives (1) participate or engage in discussions or negotiations with, and (2) subject to an Acceptable Confidentiality Agreement, (i) furnish any non-publicinformation relating to Aadi or any of its subsidiaries, and (ii) afford access to the business, properties, assets, books, records or other non-publicinformation, or any personnel, of Aadi or any of its subsidiaries to any person or group or their respective representatives that has made, renewed or delivered to Aadi an acquisition proposal after the date of the Divestiture Agreement that was not solicited in material breach of the applicable restrictions, provided that Aadi has agreed to promptly make available to